Eighty-seven patients with recent onset atrial fibrillation (≤ 8 days) without clinical signs of
heart failure were randomly allocated to one of the following treatments:(i) oral propafenone …

Aim: Oral propafenone is effective in restoring sinus rhythm however the proarrhythmic
effects are still unknown. The Safety Antiarrhythmic Therapy Evaluation (SATE) trial was a …

A population of 105 patients with recent onset (< 72 h) atrial fibrillation was randomly treated
with propafenone as a single oral loading dose of 450 mg (Regimen A) or 600 mg (Regimen …

In recent-onset atrial fibrillation, intravenous propafenone has been shown to effectively
restore sinus rhythm, whereas the efficacy of intravenous digoxin has been questioned. We …

The efficacy and safety of intravenous propafenone, amiodarone, or placebo were
compared in the treatment of atrial fibrillation (AF) of recent onset (duration≤ 48 hours) …

Study objective To compare placebo vs two different regimens of propafenone
administration—intravenous administration or short-term oral loading—in converting recent …

The effectiveness of intravenous propafenone for conversion to sinus rhythm (SR) of
paroxysmal atrial fibrillation (AF), lasting less than 7 days, was evaluated with a single-blind …

In patients with recent-onset atrial fibrillation (AF), restoration of sinus rhythm is considered
to be the first-line therapeutic option. Although this conversion might be obtained by direct …

Background: Pharmacological conversion of paroxysmal atrial fibrillation is frequently
necessary. The aim of this study was to compare intravenous propafenone, a class Ic antiar …

In a population of 417 hospitalized patients, the efficacy and safety of different drug
regimens administered to convert atrial fibrillation (AF) of recent anset (≤ 7 days duration) to …